Forum Topic News
  • Conversation: Novartis to spin off eye unit Alcon

    • June 29, 2018 12:54 PM BST
      • Post(s)

      Novartis to spin off eye unit Alcon

      Novartis has announced plans to spin off its eye-care unit Alcon into a standalone entity.
      The Swiss drug giant said it is seeking shareholder approval for the move, after a strategic review concluded spinning off the business would be consistent with Novartis’ strategy of focusing as a medicines company.
      The Alcon ophthalmology pharmaceuticals portfolio – which made 2017 sales of $4.6 billion and includes the potential blockbuster RTH258 (brolucizumab) for neovascular AMD and diabetic macular edema - will remain in house.
      Read more:

Add Reputation

Do you want to add reputation for this member by this post?

or cancel